SCM
Schnieders Capital Management’s Eli Lilly LLY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.23M | Buy |
7,993
+1,141
| +17% | +$889K | 1.09% | 25 |
|
2025
Q1 | $5.66M | Sell |
6,852
-667
| -9% | -$551K | 1.21% | 24 |
|
2024
Q4 | $5.8M | Buy |
7,519
+59
| +0.8% | +$45.5K | 1.15% | 22 |
|
2024
Q3 | $6.61M | Buy |
7,460
+281
| +4% | +$249K | 1.26% | 21 |
|
2024
Q2 | $6.5M | Buy |
7,179
+172
| +2% | +$156K | 1.31% | 22 |
|
2024
Q1 | $5.45M | Buy |
7,007
+783
| +13% | +$609K | 1.12% | 26 |
|
2023
Q4 | $3.63M | Buy |
6,224
+342
| +6% | +$199K | 0.8% | 32 |
|
2023
Q3 | $3.16M | Buy |
5,882
+2,698
| +85% | +$1.45M | 0.71% | 38 |
|
2023
Q2 | $1.49M | Buy |
3,184
+25
| +0.8% | +$11.7K | 0.31% | 62 |
|
2023
Q1 | $1.08M | Buy |
3,159
+50
| +2% | +$17.2K | 0.24% | 77 |
|
2022
Q4 | $1.14M | Hold |
3,109
| – | – | 0.26% | 75 |
|
2022
Q3 | $1.01M | Buy |
3,109
+2,409
| +344% | +$779K | 0.27% | 77 |
|
2022
Q2 | $227K | Hold |
700
| – | – | 0.07% | 167 |
|
2022
Q1 | $200K | Sell |
700
-85
| -11% | -$24.3K | 0.05% | 196 |
|
2021
Q4 | $217K | Buy |
+785
| New | +$217K | 0.05% | 193 |
|